
In this episode: How monoclonal antibodies could be the next paradigm shift in approaching COVID-19 and Long COVID clinical guidelines in Mexico.


In this episode: How can reframing pandemics as inevitable change the way we prepare for them? And resources for people with Long COVID seeking support in the accommodations process.


In this episode: How has the ongoing pandemic impacted friendships? Sociologist October Krausch looked at over 2,500 survey responses to learn more.


In this episode: Access to COVID-19 data during the federal health communication “pause”. And a breakdown about why the Affordable Care Act might be at risk, from a freelancer with Long COVID.

As scientists across the country face confusion and uncertainty following drastic changes at the National Institutes of Health (NIH) under President Donald Trump, the agency’s flagship Long COVID research program is continuing its existing work as usual. But future studies could be delayed or interrupted and prospects for additional funding are unclear under Trump’s leadership.

More research news

In this week’s episode: A blood-based biomarker for Long COVID could be on the horizon. And living with Long COVID as a Palestinian in the United States.
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS medical education national COVID-19 trends NIH NIH RECOVER podcast public health research update science Trump administration updates and events vaccines wastewater surveillance